🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07775547
Active, not recruiting Not applicable

Acupressure in Pediatric K-wire Removal

NCT07775547 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-07-01
Last updated
2026-08-20

Condition(s) studied

PainPain Management

Investigational drug(s) / intervention(s)

acupressurecontrol (placebo) group

acupressure: Participants in the placebo group will receive a touch procedure at the LI4 acupressure point without therapeutic acupressure stimulation. Pain will be assessed during and after K-wire removal. Anxiety and fear will be assessed before, during, and after the procedure.

control (placebo) group: Participants in the control group will receive a placebo acupressure procedure. Pressure will be applied to a location distant from the LI4 acupressure point, without stimulating the therapeutic LI4 point. Pain will be assessed during and after K-wire removal, while anxiety and fear will be assessed before, during, and after the procedure.

Study summary

This study aims to evaluate pain in children during and after K-wire (Kirschner wire) removal and to investigate the effect of the intervention on pain. Children who are scheduled for K-wire removal will be included in the study. Participants will be assigned to an intervention group or a control group. Pain intensity will be assessed using the Visual Analog Scale (VAS), scored from 0 to 10. Pain assessments will be performed before and after the procedure. In addition to the child's pain rating, pain will also be assessed by the parent and the researcher. The pain scores will be compared to evaluate differences between the groups and changes in pain before and after the procedure.

Eligibility

Sex
ALL
Min age
6 Years
Max age
12 Years
Healthy volunteers
Accepted
Inclusion Criteria: \- Children aged 6-12 years. First-time K-wire removal following treatment for an elbow fracture. Able to communicate verbally and understand and speak Turkish. No chronic pain, psychiatric, developmental, or sensory disorders. No physical condition preventing acupressure application at the LI4 point. No opioid, narcotic analgesic, or sedative medication use within 8 hours before the procedure. Written informed consent obtained from both the child and parent after being informed about the study. Exclusion Criteria: * Neurological or psychiatric disorders that may affect pain perception. Developmental or sensory disabilities. Inability to communicate or cooperate during the procedure. Use of opioid, narcotic analgesic, or sedative medication within 8 hours before the procedure. Requirement for analgesic or sedative medication during the procedure. K-wire removal not completed in a single session. Complications during the procedure, such as prolonged or traumatic K-wire removal. Wound, infection, dressing, fracture, inflammation, or other local contraindications at the LI4 acupressure site. Withdrawal of informed consent by the child or parent during the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Van Yuzuncu Yıl University Van Tuşba

More Cukurova University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07775547 on ClinicalTrials.gov ↗ ← All trials in Turkey